IP Library Granted Patent US 8,658,371
Granted Patent B2
US 8,658,371 · App. 13/061,286 · Granted Feb 25, 2014

Means and method for determining tumor cell percentage in a sample

Inventors: Paul Roepman (Utrecht, NL); Annuska Maria Glas (Assendelft, NL)
Assignee: Agendia B.V.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,658,371
App. No.
13/061,286
Granted
Feb 25, 2014
Kind
B2
Abstract

The invention provides a method for determining the percentage of tumor cells in a sample of an individual, preferably a breast sample. More specifically, the invention provides one or more genes than can be used to determine the percentage of tumor cells. The invention further provides a set of probes, a set of primers, and uses thereof for detection of said one or more genes.

Claims (25)

1. A method for determining the percentage of tumor cells in a cell sample of an individual, the method comprising

a. preparing RNA from a cell sample from said individual, said cell sample comprising tumor cells or suspected to comprise tumor cells;

b. determining RNA levels for a set of genes in said RNA sample; and

c. determining the percentage of tumor cells in said cell sample on the basis of the levels of RNA determined for the set of genes,

whereby the set of genes comprises genes having SEQ ID NO: 3 and SEQ ID NO: 14, and

d. selecting a sample for further analyses when the percentage of tumor cells is above a pre-determined threshold.

2. Method according to claim 1 , whereby the sample is a sample comprising breast cells of an individual suffering from a breast tumor or suspected of suffering therefrom.

3. Method according to claim 1 , wherein determining the percentage of tumor cells in a sample on the basis of RNA levels determined for a set of genes comprises comparing the RNA levels of said set of genes having SEQ ID NO: 3 and SEQ ID NO:14, to the RNA levels of said set of genes in a reference sample.

4. Method according to claim 1 , further comprising normalizing the determined RNA levels of the set of genes in the sample.

5. Method according to claim 1 , wherein the percentage of tumor cells in a sample of an individual is determined by a set of probes, wherein said probes are specific for genes having SEQ ID NO: 3 and SEQ ID NO: 14.

6. Method according to claim 5 , wherein the individual is suffering from a breast tumor or suspected of suffering there from.

7. Method according to claim 1 , wherein the percentage of tumor cells in a sample of an individual is determined by a set of primer pairs comprising primer pairs that are specific for genes having SEQ ID NO: 3 and SEQ ID NO: 14.

8. Method according to claim 7 , wherein the individual is suffering from a breast tumor or suspected of suffering there from.

9. Method according to claim 1 , wherein the percentage of tumor cells in a sample of an individual is determined by determining the level of expression of a set of genes comprising genes having SEQ ID NO: 3 and SEQ ID NO: 14 in a sample of an individual.

10. Method according to claim 9 wherein the individual is suffering from a breast tumor or suspected of suffering therefrom.

11. The method according to claim 9 , wherein the method further comprises use of primer pairs that allow the quantitative amplification of said set of genes in the sample.

12. Method of determining a percentage of tumor cells in a sample from an individual suffering from a tumor, or suspected of suffering from a tumor, the method comprising

classifying a sample as having a tumor cell percentage below or above a defined threshold by a method comprising

determining a level of RNA for a set of genes comprising genes having SEQ ID NO: 3 and SEQ ID NO: 14 in a sample from said individual;

determining a similarity value for the level of RNA in the sample and a level of RNA for the set of genes in a patient an individual having no tumor cells; and

classifying the sample as having a tumor cell percentage above the threshold if said similarity value is below a first similarity threshold value, and classifying said sample as having a tumor cell percentage below the threshold if said similarity value exceeds said first similarity threshold value, and

selecting a sample for further analyses when the tumor cell percentage is above the threshold.

13. Method according to claim 12 , whereby the defined threshold is 30%.

14. Method according to claim 12 , whereby the individual is suffering from a breast tumor or suspected of suffering there from.

15. Method according to claim 12 , whereby the set of genes comprises SEQ ID NO: 3 and SEQ ID NO: 14.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Mar 30, 2026
From: PRINSTED INVESTMENTS LLC, AS AGENT
To: AGENDIA, INC.; AGENDIA N.V.; AGENDIA INTERNATIONAL B.V.
Reel/Frame 074220/0505 →
SECURITY INTEREST Recorded Jan 15, 2025
From: AGENDIA, INC.; AGENDIA N.V.; AGENDIA INTERNATIONAL B.V.
To: PRINSTED INVESTMENTS LLC, AS AGENT
Reel/Frame 069877/0852 →
SECURITY INTEREST Recorded Oct 12, 2022
From: AGENDIA, INC.; AGENDIA N.V.; AGENDIA INTERNATIONAL B.V.
To: MIDCAP FINANCIAL TRUST
Reel/Frame 061388/0688 →
RELEASE OF GRANT OF SECURITY INTEREST IN PATENTS AT REEL/FRAME NO. 53057/0152 Recorded Aug 15, 2022
From: ATHYRIUM OPPORTUNITIES III ACQUISITION LP, AS COLLATERAL AGENT
To: AGENDIA N.V.
Reel/Frame 061178/0171 →
CHANGE OF NAME Recorded Aug 18, 2021
From: AGENDIA B.V.
To: AGENDIA N.V.
Reel/Frame 057318/0708 →
SECURITY INTEREST Recorded Jun 26, 2020
From: AGENDIA N.V.
To: ATHYRIUM OPPORTUNITIES III ACQUISITION LP
Reel/Frame 053057/0152 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 8, 2011
From: ROEPMAN, PAUL; GLAS, ANNUSKA MARIA
To: AGENDIA B.V.
Reel/Frame 026096/0418 →
Priority Claims (1)
EP 08163379 · Sep 1, 2008 · regional
Continuity (1)
Related Publication 20110269127A1 · Nov 3, 2011